MOLECULAR GENETIC MARKERS AS PREDICTORS OF SUPERFICIAL BLADDER CANCER
https://doi.org/10.17650/1726-9776-2009-5-3-19-24
Abstract
About the Authors
A. Yu. BabayanRussian Federation
S. V. Bashkatov
Russian Federation
O. B. Karyakin
Russian Federation
A. A. Teplov
Russian Federation
M. P. Golovashchenko
Russian Federation
V. V. Shkarupo
Russian Federation
D. V. Zaletayev
Russian Federation
M. V. Nemtsova
Russian Federation
References
1. Чиссов В.И., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2006 году (заболеваемость и смертность). М., 2008.
2. Матвеев Б.П., Фигурин К.Н., Корякин О.Б. Рак мочевого пузыря. М.: Вердана, 2001.
3. Heney N.M., Ahmed S., Flanagan M.J. et al. Superficial bladder cancer. J Urol 1983;130:1083—6.
4. Babjuk M., Oosterlinck W., Sylvester R. et al. Guidelines on TaT1 (non-muscle invasive) bladder cancer. Arnhem, The Netherlands: European Association of Urology (EAU), 2008.
5. Sambrook J., Fritsh E.F., Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. N.Y.: Cold Spring Harbor Laboratory Press, 1989.
6. Землякова В., Жевлова А., Стрельников В. и др. Аномальное метилирование некоторых геновсупрессоров при спорадическом раке молочной железы. Мол Биол 2003;37:696—703.
7. Кекеева Т., Жевлова А., Подистов Ю. и др. Аномальное метилирование генов супрессоров опухолевого роста и микросателлитная нестабильность в предраковых состояниях шейки матки. Мол Биол 2006;40:224—30.
8. Van Rhijn B.W., Lurkin I., Radvanyi F. et al. The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res 2001;61:1265—8.
9. Knowles M.A. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 2006;27: 361—73.
10. Mhawech-Fauceglia P., Cheney R.T., Schwaller J. Genetic alterations in urothelial bladder carcinoma. Cancer 2006;106(6):1205—16.
11. Akagashi K., Tanda H., Kato S. et al. Recurrence pattern for superficial bladder cancer. Int J Urol 2006;13(6):686—91.
12. Chapman E.J., Harnden P., Chambers P. et al. Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype. Clin Cancer Res 2005;11(16):5740—7.
13. Millan-Rodrigez F., Chechile-Toniolo R., Salvador-Bayarri J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol (Baltimore) 2000;163:68—7.
14. Ali-El-Dein B., Sarhan O., Hinev A. et al. Superficial bladder tumours: analysis of prognostic factors and construction of a predictive index. BJU Int 2003;92(4): 393—9.
15. Tada Y., Wada M., Taguchi K. et al. The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers. Cancer Res 2002;62:4048—53.
16. Карякин О.Б., Башкатов С.В., Немцова М.В. Клиническое значение молекулярно-генетических изменений в клетках уротелия при раке мочевого пузыря. Онкоурология 2006;3:54—58.
17. Sauter G., Mihatstch M.J. et al. Pussycats and baby tigers: non-invasive (pTa) and minimally invasive (pT1) bladder carcinomas are not the same! J Pathology 1998;185:339—41.
18. Effert P.J., Seifer P. Invasive potential of «noninvasive» human bladder carcinoma. Am J Clin Pathol 2003;120:188—93.
19. Kulkarni G.S., Finelli A., Fleshner N.E. et al. Optimal management of high-risk T1G3 bladder cancer. A decision analysis. PLoS Medicine 2007;4(9):1538—49.
20. Thalmann G.N., Markwalder R., Shahin O. et al. Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol 2004;172(1):70—5.
21. Masood S., Sriprasad S., Palmer J.H., Mufti G.R. T1G3 bladder cancer—indications for early cystectomy. Int Urol Nephrol 2004;36(1):41—4.
22. Manoharan M., Soloway M.S. Optimal management of the T1G3 bladder cancer. Urol Clin North Am 2005;32(2):133—45.
23. Metwalli A.R., Kamat A.M. Controversial issues and optimal management of stage T1G3 bladder cancer. Expert Rev Anticancer Ther 2006;6(8):1283—94.
24. Brandau S., Böhle A. Bladder cancer. I. Molecular and genetic basis of carcinogenesis. Eur Urol 2001;39(5):491—7.
Review
For citations:
Babayan A.Yu., Bashkatov S.V., Karyakin O.B., Teplov A.A., Golovashchenko M.P., Shkarupo V.V., Zaletayev D.V., Nemtsova M.V. MOLECULAR GENETIC MARKERS AS PREDICTORS OF SUPERFICIAL BLADDER CANCER. Cancer Urology. 2009;5(3):19-24. (In Russ.) https://doi.org/10.17650/1726-9776-2009-5-3-19-24